Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
43.44
+0.19
+(0.44%)
At close: February 21 at 5:32:18 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 11 | 11 | 15 | 16 |
| Avg. Estimate | 26.91B | 26.99B | 108.71B | 114.99B |
| Low Estimate | 26.46B | 26.46B | 106.46B | 109.55B |
| High Estimate | 27.49B | 27.44B | 111.24B | 120.17B |
| Year Ago Sales | 25.82B | 25.38B | 101.89B | 108.71B |
| Sales Growth (year/est) | 4.21% | 6.35% | 6.69% | 5.78% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| BOAC.VI | -- | -- | -- | -- |
| S&P 500 | 14.59% | 7.61% | 10.87% | 14.11% |
Upgrades & Downgrades
| Maintains | Piper Sandler: Neutral to Neutral | 1/17/2025 |
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 1/17/2025 |
| Maintains | Oppenheimer: Outperform to Outperform | 1/17/2025 |
| Maintains | Truist Securities: Buy to Buy | 1/17/2025 |
| Maintains | Evercore ISI Group: Outperform to Outperform | 1/17/2025 |
| Upgrade | UBS: Neutral to Buy | 1/7/2025 |